Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Ustekinumab in the Treatment of Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis

NCT01091051 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.

NCT NCT01091051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01091051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Ustekinumab in the Treatment of Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis
Lead sponsor
Innovaderm Research Inc.
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2010
Completion date
November 30, 2011
Enrollment
33 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

palmo-plantar pustular psoriasis, palmo-plantar pustulosis